# Calithera Biosciences, Inc.

Calithera Biosciences, Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** Calithera Biosciences, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001496671

## About

Calithera Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001496671, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-31, it reported net income of USD -39,650,000; total assets of USD 28,676,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$39.6M (USD -39,650,000)
- **Total assets:** $28.7M (USD 28,676,000)
- **Cash and equivalents:** $25.5M (USD 25,451,000)
- **Operating cash flow:** -$43.6M (USD -43,608,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $9.8M (USD 9,750,000)
- **Net income:** -$115.1M (USD -115,088,000)
- **Total assets:** $64.8M (USD 64,756,000)
- **Cash and equivalents:** $59.5M (USD 59,537,000)
- **Operating cash flow:** -$66.3M (USD -66,300,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-12-31)

- **Net income:** -$90.1M (USD -90,137,000)
- **Total assets:** $125.6M (USD 125,587,000)
- **Cash and equivalents:** $107.1M (USD 107,146,000)
- **Operating cash flow:** -$84.3M (USD -84,312,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$89.9M (USD -89,860,000)
- **Total assets:** $168.8M (USD 168,768,000)
- **Cash and equivalents:** $60.4M (USD 60,437,000)
- **Operating cash flow:** -$78.7M (USD -78,745,000)

## Recent SEC filings

- Form 10-K — filed 2023-03-31 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-01-25 — period 2023-01-24 — 8-K
- Form 8-K — filed 2023-01-09 — period 2023-01-09 — 8-K
- Form 10-Q — filed 2022-11-14 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-11-14 — period 2022-11-14 — 8-K
- Form 8-K — filed 2022-09-29 — period 2022-09-23 — 8-K
- Form 10-Q — filed 2022-08-16 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-08-15 — period 2022-08-15 — 8-K
- Form 8-K — filed 2022-06-14 — period 2022-06-14 — 8-K
- Form 8-K — filed 2022-06-03 — period 2022-06-01 — 8-K
- Form 8-K — filed 2022-05-23 — period 2022-05-23 — 8-K
- Form 10-Q — filed 2022-05-10 — period 2022-03-31 — 10-Q

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/calithera-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology